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Abstract
Current treatments of ovarian and breast cancer result in chemo resistance all too often. It has been hypothesized that
senescence-a dormant condition associated with increased age and apoptosis- may play a role in the development of
chemo resistance. We performed an in-vitro study with HOSE (carboplatin-sensitive), SKOV3 (chemo resistant ovarian
cancer), and CAMA1 (chemo resistant breast cancer) cell lines, which were exposed to a variety of platinum-based
treatments meant to model current cover clinically relevant scenarios in terms of tumor hypoxia. They were then
stained for senescence in-vitro using B-gal, and analyzed for proliferation using the Cell Counting Kit 8, trypan blue
dye exclusion, and survival plating, among other methods. Real-time quantitative PCR was used to determine relative
levels of gene expression for classical apoptotic and senescent markers. Our results indicate that proliferation was
temporarily halted in SKOV3 and CAMA1 after treatment. Cell proliferation later resumed in these cell lines while
HOSE cell underwent apoptosis. Analysis of genetic tests (such as qPCR) also revealed that SKOV3 and CAMA1 had
decreased gene expression of key genes that regulate apoptosis and senescence (such as p53 and CDK2). It can be
concluded from this data that senescence was in fact a mode of chemoresistance and that future treatments may want to
focus on disabling cancerous cells’ senescent stage.

Keywords: Ovarian cancer, Genomics, Chemo resistance, Senescence
Introduction
Rationale
Ovarian cancer affects over 240,000 women annually. More than 85% of ovarian cancers have “epithelial origin”
(Bitleret., al 2011). Therefore there is an urgent need for effective treatments for ovarian cancer. Currently, platinumbased chemotherapy, with a taxane based drug and surgery are the primary treatments for ovarian cancer.
Approximately 25% of patients introduced to platinum based chemotherapy experience tumor recurrence and develop
resistance to treatment. Chemotherapy kills tumor cells by damaging cellular integrity. It mainly targets DNA.
Chemotherapy takes away a major part of the tumor and leaves behind a few resistant cells that eventually regenerate
into a new chemo resistant tumor. The overall 5-year survival rate for advanced ovarian cancer patients is still low (20–
30%) and is due to chemo resistance in the primary or recurrent tumors, thus resulting in treatment failure. Although
ovarian cancer patients show high response rates to initial chemotherapy after cytoreductive surgery, most patients also
develop resistance to chemotherapy during treatment (Katsaros et al., 1999). Our study aimed to investigate a possible
mode of chemo resistance, senescence. The development of chemo resistance through hypoxia was also another target
of our study, as well as the pathways and genes involved in the avoidance of apoptosis.

Background on Epithelial Ovarian Cancer
Epithelial ovarian cancer is the fourth leading cause of death from female cancers in the world (Ayesha et al. 2009). A
significant portion of women with a positive response to the first treatment will develop recurrence within 18 months.
During 2003, over 24,400 new cases and 14,300 deaths were expected from epithelial ovarian cancer.
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But a 5-year survival improvement occurred in the last three decades with more aggressive surgical management and
development of more effective chemotherapy (Copeland et., al 2017). Currently, platinum-based chemotherapy is the
main treatment for epithelial ovarian cancer.

Senescence
Somatic cells include all cells of a living organism other than the reproductive cells.
Somatic cells show a spontaneous decline in growth rate in continuous culture, which is unrelated to elapsed time. Cells
enter into a quiescent but viable state termed replicative senescence. It is characterized by cells that are multinucleated
and do not respond to mitogens or apoptotic stimuli. Cellular senescence is a state of cell cycle arrest started by many
stimuli like telomere shortening, stress factors, or chemical moieties (Weiner-Gorzelet., al 2015). Multiple hypotheses
state that cellular senescence is a natural antitumor program. Senescent cells demonstrate many characteristic including
changes in “morphology and molecular signaling” (Weiner-Gorzelet., al 2015). Chemotherapy kills tumor cells by
damaging cellular integrity, most commonly that of the DNA. To limit cell death from this damage and the cellular
stress that it causes, tumor cells may enter a senescent state, sometimes long-term. In addition, “recent findings suggest
that cellular senescence is a natural mechanism to prevent undesired oncogenic stress in somatic cells that has been lost
in malignant tumors” (Mar et al).
HOSE, SKOV3, and CAMA1 ovarian cancer cell lines
Cell lines have similar genetic makeup because they are taken from one cell. It is a tool used to analyze molecular cell
markers and cellular behavior in a controlled experimental condition. In this experiment, carboplatin-sensitive, or
human ovarian surface epithelial (HOSE) and platinum-resistant (SKOV3) ovarian cancer cell lines, in addition to
CAMA1 platinum resistant breast cancer cells, were exposed to various combinations of chemotherapeutic drugs
designed to cover clinically relevant scenarios in terms of tumor hypoxia. Studies show that harmful and normal human
ovarian surface epithelial (HOSE) cells are different in their growth factors stimuli response (Tsao et., al 1995).
CAMA1 is a breast cancer cell line is used in this study because it is closely related to ovarian cancer cell lines and is
related to chemo resistance. Unlike ovarian cells, CAMA1 is a luminal-type human breast cancer cell line that displays
rounded morphology in adherent tissue culture. Genetically, CAMA1 is similar to ovarian cancer because the cells have
oncogenic mutations in PTEN and p53 and amplification of the cyclin D1 gene (Ji et. al, 1994). If ovarian cancer cell
lines show improvement of current anticancer treatments and prevent the recurrence of a cancerous tumor, then it can
correlate to breast cancer, as well.

Objective
“Given that the ultimate goal of cancer research is to find the definitive cure for as many tumor types as possible,
exploration of cellular senescence to drive towards antitumor therapies” may influence the outcome of new drugs (Mar
et al 2011). In the present paper, we will review the potential of cellular senescence to be used as a target for anticancer
therapy

Materials and Methods
Materials
HOSE 6-3, a normal human ovarian surface epithelial cell line that has been immortalized by HPV E6/7 ORF (obtained
from an affiliated research lab) cell line was used to study ovarian cancer proliferation. All cell lines were maintained
in DMEM 10% fetal bovine serum. SYBR Green I fluorescent dye, reverse transcriptase and RNase inhibitor was
purchased from Applied Biosystems, Foster City, CA. Transwell assays and reagents were obtained from BD
Bioscience. RNEasy, DNEasy were obtained from Qiagen. Cisplatin, Carboplatin, and Taxane were purchased from
Sigma and reconstituted with PBS. Primers were supplied by Sigma Genosys. Cell counting kit-8 was purchased from
Dojindo Molecular Technologies, Inc. ROS-Glo assay was purchased from Promega. Cell invasion and scratch assay
kits were supplied by Millipore. Cellular senescence kits were purchased from Dojindo Molecular Technologies and
Abcam.

Methods
Pathway Analysis
DAVID, Ingenuity, and gPROFILER are bioinformatics databases used to analyze large gene/protein lists and gain
biological meaning. Analysis was useful in gaining a better understanding of candidate genes involved in
chemoresistance in ovarian cancer. Once an uploaded gene list is obtained, analysis can be performed in order to
classify the genes based on different mechanisms and pathways that coincide with our study. PubMed meta analysis
can be done with smaller gene lists of interest to gain information on chemo resistant mechanisms.
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International Journal of Applied Science and Technology

Vol. 9, No. 2, June 2019

doi:10.30845/ijast.v9n2p2

Chemotherapy Sensitivity and Survival
The breast and ovarian cell lines HOSE, SKOV3, and CAMA1 were tested for IC20, IC50 and IC80 carboplatin
sensitivity levels. Cells were seeded at 10^3 cells/well in a 96 well plate and treated with platinum and/or taxol
treatments at a concentration range of 1–100 μg/ml in 100 μl of fully supplemented medium. After a period of 72
hours, cytotoxicity was assessed by trypan blue dye exclusion viability assay using 1:100 dilutions in cell culture
suspensions.
Additionally, the CCK-8 assay was used to measure cell survival after treatment with drugs following the
manufacturer’s protocol and absorbance measured at 450 nm using the Biotek EL800 spectrophotometer. For survival
plating, cells were harvested the 36 hours after chemotherapy treatment using trypsinization, counted, and a specific
number of cells (500 and 250 cells) was plated in petri dishes in triplicate for clonogenic assay. “Dishes were placed in
an incubator and left there for 9 days until large clones (> 1 mm) were formed (50 cells or more). Staining of colonies
was done by removing medium and washing cells twice with PBS. Fixation and staining of clones was done with a
mixture of 0.5% crystal violet in 50/50 methanol/water for 30 min” (Karl et al 2012). Dishes were rinsed with water
and left for drying at room temperature. Counting of clones was done on the following day.
Cell Proliferation Assay
Cells were seeded into 6-well plates at 10,000 cells/mL in DMEM supplemented with 10% FBS, 1% L-glutamine, 1%
penicillin-streptomycin from Invitrogen. Cells were washed in PBS, trypsinized, and counted using a 1:1 0.4% trypan
blue solution every three days for growth and viability analysis. Viable cells with no blue stain and dead cells with blue
stain were counted using a hemocytometer. Proliferation and metabolic activity was determined using alamar blue dye
assay and spectrophotometry using the Biotek EL800 at 600nm.
Scratch Assay
This method is used to measure the migration of individual cells in vitro and overall to mimic migration of cells in
vivo. The scratch assay can be performed on either native cells or transfected cells to study the effect of specific protein
overexpression on cell migration. The lab used scratch assay on transfected cells. A “wound” or scratch is made
through the monolayer of cells. The ability for the cells to migrate towards the center of the gap between the cells is
tested. The Cell Comb Kit assay and manual from Millipore was used.
Invasion Assay
An invasion assay was performed to count the number of cells with the ability to invade through an extracellular
matrix. These characteristics reflect those found in tumor cells. The assay used was the CHEMICON Cell Invasion
Assay kit. Cells were plated on a 24-well tissue culture plate and the EC-MatrixTM layered cell culture inserts were
used in the invasion chamber. Cells were serum starved for a period of 16 hours before the assay was performed. The
serum-starved cells were placed on the 24-well tissue culture plate. 750 μl of DMEM with 15% FBS were added into
the lower wells as a chemo attractant for the starved cells. Cells were incubated for a period of 24 hours. The invading
cells that passed through the membrane fixed with 4% methanol in PBS were stained accordingly with crystal violet.
The results of the invading cells were counted with a bright field microscope.
ROS-Glo H2O2 Assay
“Reactive oxygen species (ROS) are chemically reactive molecules that contain oxygen. ROS are beneficial to the cell,
having roles in cell signaling and as natural byproducts of normal metabolism” (Alfassa and Sallam, 2012). ROS can
also lead to cellular damage, or oxidative stress, as a result of environmental factors (e.g., chemotherapy). The ROSGlo assay was performed according to the manufacturer’s instructions. Luminescence was measured on a Molecular
Device’s SpectraMax i3x plate reader (excitation 485nm, emission 520nm).
Colorimetric Caspase-3 Apoptosis Assay
The caspase 3 Assay Kit (Colorimetric) (ab39401) measures the activity of caspases using spectrophotometric
detection. It was used according to the manufacturer’s instructions.
Real-time qPCR
Total cellular RNA was isolated using RNeasy kit and 1ug of RNA was reverse transcribed to cDNA using the
SuperScript One Step RT-PCR system by Invitrogen, according to the manufacturer’s instructions. cDNA at a 1:10
dilution was used for all PCR reactions and primers were designed by Sigma. Primer sequences are as follows: Caspase
3,5′-TGACTGGAAAGCCGAAACTC 3′ and 5′-AGCCTCCACCGGTATCTTCT-3′; Caspase 8,
5′- CCGAGCTGGACT TGTGACC -3′ and 5′- CTGCCCAGTTCTTCAGCAAT-3′ and HPRT,
5′ CTTCCTCCTCAGACCGCTTT -3′ and 5′- TTTCCAAATCCTCGGCATAA- 3′. Amplified
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Fragment sizes were 122, 118 and 145 bp for Caspase 3, Caspase 8 and HPRT, respectively. All PCR reactions were
performed on CFX-96 Bio-Rad RT System in triplicate and validated by the presence of a single peak in the melt curve
analysis. Changes in gene expression were calculated relative to the HPRT control. PCR products were electrophoresed
through 1.0% agarose gel, stained with ethidium bromide and visualized under ultraviolet illumination. Band intensity
calculated using Image-J software (Bio- Levels of mRNA were expressed as the ratio of band intensity relative to that
for control).
Senescence
Senescence induced by chemotherapy regimens were stained using Millipore’s senescence-associated β-galactosidase
(SA-β-gal) assay or Abcam Senescence Detection Kit (ab6535) according to the manufacturer's protocol. After a 72
hour treatment with carboplatin, cells were washed 1x with phosphate buffered saline, fixed in a 1x fixative (provided)
and stained using a freshly prepared and protected from light SA-βgal solution. Next, the plates were wrapped in
aluminum foil to protect them from light and were placed in an incubator at 37°C and 5% CO2 for 48 hours. The cells
were removed from the incubator and the stain was aspirated off the plates. Cells that were stained for senescenceassociated β-galactosidase activity were stained blue under standard light microscopy. The percentage of positively
blue stained cells was determined by scoring six random high power fields per well in a 6-well plate.

Results
David Pathway Analysis
Signal transduction pathways highlighted include: transcription regulation genes, intracellular transport, glucose
metabolic process, EMT, cellular response to stress, negative regulation of gene expression, and apoptosis and
senescence. Common genes of interest highlighted in our bioinformatics screen included TP53, PTEN, CASP3,
CDKN1A, CDK2, and ID1. We validated these genes by running gene expression analysis on our cell lines. RNA is
reverse transcribed and the resulting cDNA is used as a template in the qPCR reaction to detect and quantitate gene
expression products.
Survival Assay
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CCK8

As shown by the graphs and tables above, SKOV3 and CAMA1 showed increased proliferation compared to
HOSE.
Scratch Assay

The above picture shows that SKOV3 displayed significant cell migration. CAMA1 also shows cell migration
after 18 hours. Hose shows very little migration. All cell lines were treated with carboplatin before the assay was
performed.
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Invasion Assay

The invasion assay above shows the aggressiveness of each cell line after treatment with carboplatin. SKOV3
and CAMA1 are recorded as exhibiting aggressive behavior. Hose does not exhibit this aggressive growth.
ROS-Glo H2O2 Assay

Colorimetric Caspase-3 Apoptosis Assay
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Real-time qPCR

The blue stains in the above picture are cells in a senescent state. SKOV3 cells have a notable number of blue stains.

Discussion
The survival assay, CCK8 assay, scratch assay, invasion assay, ROS-Glo H2O2 Assay, and Colorimetric Caspase-3
Apoptosis Assay all draw similar expected conclusions. SKOV3 (ovarian cancer) and CAMA1 (breast cancer) cell lines
showed much more aggressive behavior after an extended time following platinum based treatment compared to the
HOSE (normal human ovarian surface epithelial cells) cell line.
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The survival assay showed that on average, after treatment with carboplatin, HOSE cells had a 0.102% survival rate
compared to 0.492% for CAMA1 and 0.557% for SKOV3. This significant difference between the two cancerous cell
lines compared to the HOSE cells lines points to the conclusion that CAMA1 and SKOV3 cell lines are able to avoid
apoptosis after treatment. The CCK assay results point to suspicious dormant behavior in the CAMA1 and SKOV3 cell
lines immediately after treatment. Cell proliferation is decreased directly after treatment, which provides evidence that
the two chemoresistant cell lines enter a senescent stage that temporarily halts all activity. The HOSE cells continues to
proliferate after treatment before apoptosis is ultimately triggered, and do not enter a senescent stage.
The scratch assay visually showed that SKOV3 and CAMA1 had similar cell migration after 18 hours. They both had
much more migration and therefore increased vitality compared to the HOSE cell lines during an extended period of
time following treatment with apoptosis inducing drugs. The invasion assay also visibly showed the increased
aggressiveness of CAMA1 and SKOV3 compared to HOSE. These two cell cells lines had more invasive cells in their
colonies that were able to pass through a membrane. The membrane models the epithelial membrane that theoretically
prevents the cells from reaching the circulatory system when present in vivo.
“The ROS-Glo H202 Assay measured the level of hydrogen peroxide, a reactive oxygen species (ROS), found directly
in the cell culture or in defined enzyme reactions” (Promega 2016). Increased levels of ROS result in more cell death
after treatment with chemotherapy.
Increased levels of ROS are revealed through increased luminescence. The HOSE cells that were treated with
carboplatin had an average luminescence (in relative light units) of 480,000, compared to 290,000 RLU for CAMA1,
and 125,000 RLU for SKOV3. The noticeable difference between the two cancerous cell lines (CAMA1 and SKOV3)
and the normal epithelial cell line (HOSE) further points out the ineffectiveness of apoptosis inducing drugs on
chemoresistant cancers.
Caspase-3 is an enzyme that is involved in the execution of apoptosis. Increased levels of caspase-3 indicate increased
apoptotic bodies (ABs). The Caspase-3 assay uses cell staining to identify caspase-3 activity. Our data indicates that
HOSE had the most activity, and therefore the
most apoptotic bodies. The average percent of apoptotic bodies in the carboplatin treated HOSE colony was 78.35%.
CAMA1 and SKOV3 populations had 69.33% and 24.15% of the population experience apoptosis (respectively). It can
be concluded that chemotherapy was more effective in HOSE than SKOV3 and CAMA1.
Real-time qPCR (Quantitative polymerase chain reaction) reveals certain DNA sequences and helps quantify their
presence. Further research can then be done to determine the role of those identified sequences. After running qPCR
tests on HOSE and SKOV3, it was revealed that CASP3, CDKNIA, TP53, and CDK2, along with other genes had
increased expression in HOSE. These genes are mainly involved in regulating the cell cycle and triggering apoptosis. In
addition, TP53 in particular has been associated with both apoptosis and senescence. It can be concluded that decreased
gene expression of CASP3, TP53, and other genes that regulate the cell cycle and apoptosis, go hand in hand with
senescence. A decrease in gene expression may even trigger or lead to a cancerous cell entering the senescent stage and
becoming chemoresistant after treatment. Further research is need to support this.
The test for senescence using Millipore’s senescence-associated β-galactosidase
(SA-β-gal) assay or Abcam Senescence Detection Kit shows significant blue-stained cells in the SKOV3 colonies. The
CAMA1 cells closely compare with the HOSE colony, though. The blue stain indicates cells in the senescent stage. The
senescent stage can almost be classified as a hibernation state for cancerous cells. In normal cells, it plays a role in
natural apoptosis and is a common aspect of aging in cells. Once a cell enters the senescent stage in response to various
stressors, proliferation is arrested. Past research has shown that senescence plays a role in age related diseases, and it is
currently hypothesized that the senescent stage is manipulated by chemoresistant cancerous cell lines in order to
avoiding induced apoptosis after treatment with chemotherapy.
As the results from our tests show, one chemoresistant cell line entered the senescent stage after being introduced to a
variety of platinum based treatments meant to replicate current treatments in hospitals. This partially confirms past
hypothesis, but explores aspects of chemoresistance that have not been extensively explored yet, such as the link
between senescence and decreased gene regulation. Statistical evaluation further shows that both HOSE and CAMA1
had p-values from a t-test of approximately 0.9. Therefore, these two cell lines are not significantly different. SKOV3
had a p-value of approximately 0.08, which still does not qualify as significantly different, but it is close to being
significantly different with a p-value of 0.05. While this is not the results that were hoped for, an interesting trend is
apparent. While both CAMA1 and SKOV3 are chemoresistant and exhibit deregulation of genes such as p53, only
SKOV3 exhibited somewhat of a senescent state in the actual senescence assay, even though both SKOV3 and
CAMA1 had senescent-like behavior in the proliferation and vitality assays.
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This may be explained by possible incorrect procedures when staining CAMA1, unknown factors (such as
contamination), or the possibility that more factors are involved in the connection between similar genetic expression
and senescence as a mode of chemoresistance.
Senescence “has emerged as a potentially important contributor to aging and age-related disease, and it is an attractive
target for therapeutic exploitation,” not just in age-related diseases, but also in cancer (Childs, et al. 2016). Senescence
may be a significant tool in the recurrence of tumors. Our in vitro observation that chemotherapy agents not only
promote apoptosis but can also induce cellular senescence in SKOV3 indicates that genes that control senescence might
also determine treatment outcome. It is also observed that chemotherapeutic drugs induced senescence in p53- and
p16-defective tumor cell lines (like breast and ovarian) and therefore may be simultaneously playing a dual role in
apoptosis and senescence.

Conclusions and Future Work
The goal of this research was to investigate senescence as a mode of chemoresistance in ovarian and breast cancer cell
lines and to pinpoint genes whose expression was associated with hypoxia-induced chemoresistance and the incitement
of senescence. We achieved these goals by using SKOV3 (ovarian cancer), HOSE (normal epithelial cells), and
CAMA1(breast cancer cells), which were treated with various forms of platinum-based chemotherapy and experienced
induced hypoxia. These treatments resulted in SKOV3 and CAMA1 cells entering a senescent stage, which led us to
the conclusion that senescence serves as a form of “hibernation” for cancerous cells. This dormant period allows them
to avoid cell death during treatment, then continue to proliferate afterwards. During this experiment, we also learned
that p53 was a gene that played a role in chemoresistance, as proved by past literature and previous studies, including
our study. Since ovarian and breast cancer are p53- and p16-defective tumor cell lines, this gene may be simultaneously
playing a dual role in apoptosis and senescence.
Our conclusions coincide with past studies on the nature of cancer and its unique molecular events that govern the
emergence of aggressive therapy-resistant cells with unique cell properties after chemotherapy. However, our results
may have been influenced by a few factors that were out of our control. For example, during the course of the
experiment, a few cell wells became infected with mold or bacteria and had to be discarded. Since we did an in vitro
study, some deviation from typical conditions and behaviors can be expected. The best results would be those from
actual tumor samples. In the future, our conclusions can be refined by duplicating this experiment with actual tumor
samples instead of in vitro grown cell colonies. Different cell lines can also be examined to see if senescence is a
common pathway for chemoresistance in other forms of cancer.
Due to time limitations, we were unable to run a qPCR test on CAMA1. If we were to redo our experiment, we would
include this data to further support our conclusions. The use of a qPCR in another similar experiment could be used to
explore gene expression in hypoxia by revealing certain DNA sequences and quantifying their presence. Finally we
would use a Western Blot test to identify specific protein expressions of the genes involved in apoptosis and the cell
cycle (such as p53).
After the completion of this investigation, some questions still remain. While we investigated the role that senescence
plays in the development of chemoresistance, we are not entirely sure just how senescence functions in the deregulation
of the cell cycle. Certain genes and pathways that influence this deregulation may still lie undiscovered, as well.
Ultimately, the goal of this research is to help develop an anticancer treatment that does not lead to chemoresistance.
This is still a work in progress in the research field. Our research helps brings modern medicine a step closer to a better
cure. Overarchingly, improved understanding of the molecular mechanisms underlying drug resistance in cancer cells
could be useful for devising targeted therapeutic approaches. Senescence is just one of the many pathways cells take to
outcompete chemotherapy. It is our aim to increase understanding of molecular cues in cancer cells, which can result in
better outcomes than those currently achieved using conventional approaches alone.
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